Back to search results

Transition to Cardiac Rehabilitation (T2CR) for Cardiovascular Disease

This study is testing a new program called T2CR Intervention to help Veterans with heart conditions get the most out of cardiac rehabilitation (CR). CR helps you recover after a heart event. Many Veterans don't participate in CR, especially if they have other health problems or frailty (weakness). The T2CR Intervention is a two-phase program that starts during or shortly after you leave the hospital. It helps you assess your risks and develop strategies to improve your function through education. The study will compare the T2CR Intervention to usual care, which is what your doctors normally recommend. We are looking for 250 Veterans, aged 18 and older, who have been hospitalized for conditions like heart attack, bypass surgery, valve problems, or heart failure. Success will be measured by changes in your physical function over three months.

Study design
This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 250 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for at least 3 months to measure changes in physical function.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06244199

Transition to Cardiac Rehabilitation (T2CR) to Address Barriers of Multimorbidity and Frailty

Recruiting
NAAges 18+InterventionalTreatment
VA Office of Research and Development
~250 participants
Updated 2025-10-22 on ClinicalTrials.gov
What's tested:T2CR InterventionUsual Care

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
PROMIS Physical Function SF 10a
Measured over 3 months, i.e., baseline to 3-month change

Conditions

Cardiovascular Diseases
Cardiac Rehabilitation
Transition of Care

Explore related trials

Heart FailureIschemic Heart DiseaseValvular Heart Disorder

Where it's being run

2 sites across 2 states
Massachusetts1
Pennsylvania1

Study leadership

  • Daniel E Forman, MD · PRINCIPAL_INVESTIGATOR · VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA

Who to contact

Daniel E Forman, MD
[email protected]
(412) 360-2917
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Eligible candidates will consist of male and female Veterans hospitalized with:
ischemic heart disease (acute myocardial infarction or stable ischemia)
revascularization (coronary artery bypass grafting or percutaneous coronary intervention)
valvular heart disease (surgical or percutaneous intervention for mitral regurgitation or aortic stenosis)
or heart failure (with reduced or preserved ejection fraction)
All will be recruited while initially hospitalized and must express willingness to consider cardiac rehabilitation as a treatment option, including the possibility of the intervention which could possibly extend the length of their hospitalization (for 2 days maximum).
Study candidates must also be English speaking and able to provide written informed consent

Exclusion

Veterans with unstable medical condition as indicated by history, physical exam, and/or laboratory findings end-stage disease likely to be fatal within 12 months
severe cognitive impairment (MiniCog score 0-2)
history of addictive or behavioral issues that confound safe administration of HBCR
hearing loss that interferes with participation in the trial
living in a long-term care living situation prior to the time of hospitalization, no plans to return to independent living after the hospitalization

What this trial measures

  • PROMIS Physical Function SF 10a3 months, i.e., baseline to 3-month change

    The Patient Reported Outcomes Measurement Information System (PROMIS) Physical Function V2.0 Short Form 10a is a standardized patient reported index of practical functional capacity. PROMIS physical function instruments measure self-reported capability and functioning of upper extremities (dexterity), lower extremities (walking or mobility), as well as instrumental activities of daily living. The PROMIS Physical Function Short Form 10a is a standardized questionnaire appropriate for comparing large groups. The Physical Function scaled score is applied as the primary outcome at 90 days.